- Home
- CENTA vs APGE Comparison
CENTA vs APGE Comparison
Compare CENTA & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENTA
- APGE
- Stock Information
- Founded
- CENTA 1955
- APGE 2022
- Country
- CENTA United States
- APGE United States
- Employees
- CENTA N/A
- APGE N/A
- Industry
- CENTA Consumer Specialties
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CENTA Consumer Discretionary
- APGE Health Care
- Exchange
- CENTA Nasdaq
- APGE Nasdaq
- Market Cap
- CENTA 2.0B
- APGE 2.3B
- IPO Year
- CENTA 1993
- APGE 2023
- Fundamental
- Price
- CENTA $32.05
- APGE $34.55
- Analyst Decision
- CENTA Strong Buy
- APGE Strong Buy
- Analyst Count
- CENTA 5
- APGE 5
- Target Price
- CENTA $41.50
- APGE $83.50
- AVG Volume (30 Days)
- CENTA 245.6K
- APGE 499.8K
- Earning Date
- CENTA 02-05-2025
- APGE 03-04-2025
- Dividend Yield
- CENTA N/A
- APGE N/A
- EPS Growth
- CENTA N/A
- APGE N/A
- EPS
- CENTA 1.82
- APGE N/A
- Revenue
- CENTA $3,222,363,000.00
- APGE N/A
- Revenue This Year
- CENTA $2.92
- APGE N/A
- Revenue Next Year
- CENTA $2.16
- APGE N/A
- P/E Ratio
- CENTA $17.61
- APGE N/A
- Revenue Growth
- CENTA N/A
- APGE N/A
- 52 Week Low
- CENTA $27.70
- APGE $32.46
- 52 Week High
- CENTA $41.03
- APGE $72.29
- Technical
- Relative Strength Index (RSI)
- CENTA 48.08
- APGE 35.39
- Support Level
- CENTA $32.17
- APGE $32.46
- Resistance Level
- CENTA $34.14
- APGE $37.42
- Average True Range (ATR)
- CENTA 0.97
- APGE 2.17
- MACD
- CENTA -0.02
- APGE -0.30
- Stochastic Oscillator
- CENTA 33.19
- APGE 20.84
About CENTA Central Garden & Pet Company Nonvoting
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.